An innovative pharma company determined to provide our communities with the most effective healthcare solutions from prevention to treatment
AJ Research and Pharma (AJRP), a wholly-owned subsidiary of AJ Pharma Holding Sdn Bhd, is an integrated healthcare and life sciences company founded by Saudi-based Aljomaih Group. AJRP is headquartered in Kuala Lumpur, Malaysia and functions as the pharmaceutical and nutraceutical manufacturing and commercial arm of the holding company. Our focus is on developing unique products and delivery systems for a range of pharmaceutical and nutraceutical segments. We are well-positioned to expand and strengthen the group’s regional footprint to serve the community better. We strongly believe in continuous learning and improving through partnerships and collaborations. Our business partners include leading technology-based pharmaceutical and nutraceutical companies.
The Aljomaih Group itself is based in Saudi Arabia, and is one of the top 10 investment groups in that region. Established in 1936, the Group has made investments in various sectors globally, including oil and gas, healthcare and life sciences, food and beverage as well as the automotive sectors. The company was attracted to Malaysia’s value proposition and hence initiated several investment options in Malaysia and the region.
AJ Pharma Holding
AJ Pharma Holding was established by the Aljomaih Group of Saudi Arabia as a dedicated, Malaysia-based healthcare investment company.
The Group’s investment philosophy is a coherent way of thinking about markets and its UNMET needs, how they work and the time-frame that is needed to determine the success of an investment. The Group’s investment strategy differs from most, as it is based on a set of outcomes that are community-centric. It is a set of core beliefs that gets the Group recognised as a strategic, social and financial contributor to the domain and region it enters.
Our Group strongly believes in continuous learning and improving through partnerships and collaborations in our investments.
AJRP and AJ Biologics, wholly-owned subsidiaries of AJ Pharma Holding, support and complement the roles of the parent company.
AJ Biologics is a vaccine manufacturing facility with formulation, fill and finish packaging capabilities.
It was established as the flagship investment of AJ Pharma Holding to address key areas within the healthcare biotechnology sector. The AJ Biologics vaccine manufacturing facility will adheres to Current Good Manufacturing Practice (CGMP) and international accreditation standards such as the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S), European Medicines Agency (EMEA) and the World Health Organization (WHO).
With “flexible manufacturing” technology, equipment and design, the completed facility will be able to produce a range of finished dosage forms consisting of prefilled syringes, liquid vials, and lyophilised vials. With the facility at the region’s doorstep, good healthcare will be more accessible and meet the needs of the region’s community in a timely manner.
Have a Question?
Chat with Us!